Update on the phase III VISTA trial
19 Dec 2011
Update on the phase III VISTA trial
Treatment of breast cancer as a chronic disease
Everolimus improved PFS in advanced hormone receptor positive breast cancer
Anaemia management update: blood transfusion and ESA use in oncology
Translational research and proteasome inhibitors in multiple myeloma
Advances in the treatment of T-cell lymphoma
Key research from the 9th International Workshop for Lymphoma
Active angiogenesis drugs in development
PARP inhibitory treatment for BRCA mutated and sporadic triple negative breast cancer
Chemotherapy Foundation Symposium 2011
New trastuzumab combinations for HER2 positive breast cancer
Antiangiogenic therapies for non-small cell lung cancer